Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: NCT04401202 Eligibility Criteria

version: 3; Last updated: 2026-08-05 07:33:36+0000

ArtifactPublicationStatus: Active

Artifact Author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:

CiteAs:

NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json.

url: https://fevir.net/resources/Group/189713

identifier: FEvIR Object Identifier/189713, FEvIR Linking Identifier/NCT04401202 Eligibility Criteria

name: NCT04401202_Eligibility_Criteria

title: NCT04401202 Eligibility Criteria

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Inclusion Criteria:

  • Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia
  • Adult (18 Years and above)
  • Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).
  • Understands and agrees to comply with planned study procedures.
  • Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH. Exclusion Criteria:
  • Patients with pneumonia or severe illness requiring admission to ICU.
  • Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis
  • Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).
  • Pregnancy or breast feeding.
  • Anticipated transfer to another hospital which is not a study site within 72 hours.
  • Allergy to any study medication.

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

membership: Conceptual

combinationMethod: All of

characteristic

code: Defined by CodeableConcept

value: Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia

exclude: false

description:

Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia

characteristic

code: Defined by CodeableConcept

value: Adult (18 Years and above)

exclude: false

description:

Adult (18 Years and above)

characteristic

code: Defined by CodeableConcept

value: Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).

exclude: false

description:

Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).

characteristic

code: Defined by CodeableConcept

value: Understands and agrees to comply with planned study procedures.

exclude: false

description:

Understands and agrees to comply with planned study procedures.

characteristic

code: Defined by CodeableConcept

value: Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.

exclude: false

description:

Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.

characteristic

code: Defined by CodeableConcept

value: Patients with pneumonia or severe illness requiring admission to ICU.

exclude: true

description:

Patients with pneumonia or severe illness requiring admission to ICU.

characteristic

code: Defined by CodeableConcept

value: Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \< 30) or end stage renal disease requiring dialysis

exclude: true

description:

Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis

characteristic

code: Defined by CodeableConcept

value: Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \> 5 times the upper limit of normal).

exclude: true

description:

Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).

characteristic

code: Defined by CodeableConcept

value: Pregnancy or breast feeding.

exclude: true

description:

Pregnancy or breast feeding.

characteristic

code: Defined by CodeableConcept

value: Anticipated transfer to another hospital which is not a study site within 72 hours.

exclude: true

description:

Anticipated transfer to another hospital which is not a study site within 72 hours.

characteristic

code: Defined by CodeableConcept

value: Allergy to any study medication.

exclude: true

description:

Allergy to any study medication.